Many insurers, including UnitedHealthcare, historically classify obesity medications as "lifestyle" drugs and exclude them from standard pharmacy benefits
Doctors struggle to diagnose patients on GLP-1 receptor agonists who come in with stomach problems
Most patients should receive metformin initially, but if control is suboptimal after 36 months, treatment intensification with another glucose-lowering therapy is required, and selection of subsequent therapies should be made on an individualized basis to meet the specific needs of the patient (4)
However, -arrestin-1 knockdown did not affect GLP-1 R surface expression and ligand-induced GLP-1 R internalization/desensitization
The hypothalamus contains receptors that monitor blood concentration and trigger thirst when needed
Understanding these nutritional challenges is essential for optimizing therapeutic outcomes while maintaining overall health